Medicare Enrolled

Sarah Rowe, MSN, FNP-BC, OCN

Nurse Practitioner - Family · Panama City, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
615 N BONITA AVE STE 2-F, Panama City, FL 32401
8508047500
Registered in NPPES since 2018
NPI: 1427549765 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Rowe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Rowe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Rowe

Sarah Rowe is a nurse practitioner - family in Panama City, FL, with 8 years of NPI registration. Based on federal Medicare data, Rowe performed 823 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Rowe received a total of $8,513 from 54 pharmaceutical and/or device companies across 345 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Rowe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years of NPI registration ▲ Top 21% volume in FL $8,513 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
823
Medicare services
Top 21% in FL for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
435 $43 $76
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
237 $65 $112
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
41 $52 $93
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $23 $40
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
27 $22 $95
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
25 $86 $151
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $95 $187
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
11 $47 $88
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,513
Total received (2021-2024)
Avg $2,128/year across 4 years
Top 2% in FL for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
345
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,699
2023
$1,765
2022
$607
2021
$2,442

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$1,409
AstraZeneca Pharmaceuticals LP
$225
Regeneron Healthcare Solutions, Inc.
$219
Janssen Biotech, Inc.
$156
GENZYME CORPORATION
$147
ABBVIE INC.
$137
Exelixis Inc.
$137
E.R. Squibb & Sons, L.L.C.
$124
Celgene Corporation
$113
GlaxoSmithKline, LLC.
$103
Genentech USA, Inc.
$100
Takeda Pharmaceuticals U.S.A., Inc.
$82
Merck Sharp & Dohme LLC
$80
Astellas Pharma US Inc
$80
BeiGene USA, Inc.
$75
Eisai Inc.
$71
PFIZER INC.
$67
Incyte Corporation
$62
Daiichi Sankyo Inc.
$58
Apellis Pharmaceuticals, Inc.
$45
JAZZ PHARMACEUTICALS INC.
$30
CSL Behring
$26
Ipsen Biopharmaceuticals, Inc
$24
PUMA BIOTECHNOLOGY, INC.
$22
ARRAY BIOPHARMA INC
$21
Alnylam Pharmaceuticals Inc.
$19
Pharmacosmos Therapeutics Inc.
$19
TAIHO ONCOLOGY, INC.
$17
Stemline Therapeutics Inc.
$17
Aveo Pharmaceuticals, Inc.
$14
Top 3 companies account for 50.1% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$2,356
Janssen Biotech, Inc.
$571
AstraZeneca Pharmaceuticals LP
$558
E.R. Squibb & Sons, L.L.C.
$413
Celgene Corporation
$411
Regeneron Healthcare Solutions, Inc.
$403
Amgen Inc.
$326
Merck Sharp & Dohme LLC
$236
ABBVIE INC.
$216
GENZYME CORPORATION
$214
Astellas Pharma US Inc
$176
Incyte Corporation
$166
Genentech USA, Inc.
$165
Eisai Inc.
$160
GlaxoSmithKline, LLC.
$156
Merck Sharp & Dohme Corporation
$145
BeiGene USA, Inc.
$139
Exelixis Inc.
$137
Pharmacyclics LLC, An AbbVie Company
$130
Daiichi Sankyo Inc.
$121
Stemline Therapeutics Inc.
$109
Lilly USA, LLC
$83
Takeda Pharmaceuticals U.S.A., Inc.
$82
SANOFI-AVENTIS U.S. LLC
$78
Apellis Pharmaceuticals, Inc.
$68
Foundation Medicine, Inc.
$68
PFIZER INC.
$67
Ipsen Biopharmaceuticals, Inc
$62
CSL Behring
$60
Seagen Inc.
$56
Gilead Sciences, Inc.
$48
Karyopharm Therapeutics Inc.
$47
Blueprint Medicines Corporation
$38
ARRAY BIOPHARMA INC
$38
Teva Pharmaceuticals USA, Inc.
$33
Myriad Genetic Laboratories, Inc.
$32
Aveo Pharmaceuticals, Inc.
$32
Rigel Pharmaceuticals, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$30
Progenics Pharmaceuticals, Inc.
$23
SOBI, INC
$22
PUMA BIOTECHNOLOGY, INC.
$22
Alnylam Pharmaceuticals Inc.
$19
Pharmacosmos Therapeutics Inc.
$19
MorphoSys, US Inc.
$18
TAIHO ONCOLOGY, INC.
$17
EISAI INC.
$17
ADC Therapeutics America, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Dova Pharmaceuticals
$14
Janssen Pharmaceuticals, Inc
$14
Myovant Sciences Inc.
$13
Servier Pharmaceuticals LLC
$13
Coherus Biosciences Inc.
$11
Top 3 companies account for 40.9% of all-time payments
Associated products mentioned in payments ›
ALPROLIX · ASPARLAS · AYVAKIT · Afstyla · Alecensa · BALVERSA · BENDEKA · BLENREP · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Columvi · DARZALEX · Doptelet · ELAHERE · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Empaveli · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Idelvion · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYLARIFY · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · TAGRISSO · TASIGNA · TECVAYLI · TIVDAK · Tavalisse · Tecentriq · Trodelvy · Truxima · Udenyca · VENCLEXTA · Venclexta · XALKORI · XARELTO · XPOVIO · Xospata · Xtandi · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in Panama City?
Compare family nurse practitioners in the Panama City area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
192
County median income
$70,188
Nearest hospital to ZIP centroid (approximate)
ASCENSION SACRED HEART BAY
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Rowe is a clinical cardiology specialist, with above-average Medicare volume (top 21% in FL).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Rowe experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Rowe performed 435 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Rowe receive payments from pharmaceutical companies?
Yes. Rowe received a total of $8,513 from 54 companies across 345 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Rowe's costs compare to other family nurse practitioners in Panama City?
Rowe's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Rowe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →